rs1085307993
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP2PP3PP5_Very_Strong
The NM_001371727.1(GABRB2):c.904G>A(p.Val302Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Consequence
GABRB2
NM_001371727.1 missense
NM_001371727.1 missense
Scores
12
6
1
Clinical Significance
Conservation
PhyloP100: 7.81
Genes affected
GABRB2 (HGNC:4082): (gamma-aminobutyric acid type A receptor subunit beta2) The gamma-aminobutyric acid (GABA) A receptor is a multisubunit chloride channel that mediates the fastest inhibitory synaptic transmission in the central nervous system. This gene encodes GABA A receptor, beta 2 subunit. It is mapped to chromosome 5q34 in a cluster comprised of genes encoding alpha 1 and gamma 2 subunits of the GABA A receptor. Alternative splicing of this gene generates 2 transcript variants, differing by a 114 bp insertion. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), GABRB2. . Gene score misZ 3.3968 (greater than the threshold 3.09). Trascript score misZ 4.0905 (greater than threshold 3.09). GenCC has associacion of gene with undetermined early-onset epileptic encephalopathy, epileptic encephalopathy, infantile or early childhood, 2.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.801
PP5
Variant 5-161331056-C-T is Pathogenic according to our data. Variant chr5-161331056-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 427157.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-161331056-C-T is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRB2 | NM_001371727.1 | c.904G>A | p.Val302Met | missense_variant | 8/10 | ENST00000393959.6 | NP_001358656.1 | |
GABRB2 | NM_021911.3 | c.904G>A | p.Val302Met | missense_variant | 9/11 | NP_068711.1 | ||
GABRB2 | NM_000813.3 | c.904G>A | p.Val302Met | missense_variant | 9/10 | NP_000804.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRB2 | ENST00000393959.6 | c.904G>A | p.Val302Met | missense_variant | 8/10 | 1 | NM_001371727.1 | ENSP00000377531 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Epileptic encephalopathy, infantile or early childhood, 2 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Undiagnosed Diseases Network, NIH | Mar 17, 2018 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 31, 2018 | The V302M variant in the GABRB2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The V302M variant is not observed in large population cohorts (Lek et al., 2016). The V302M variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. Missense variants in nearby residues (K303R, A304V) have been reported in the Human Gene Mutation Database in association with GABRB2-related disorder (Stenson et al., 2014), supporting the functional importance of this region of the protein. We interpret V302M as a pathogenic variant. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
D;D;.;D;.;D;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;.;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
M;M;M;.;M;.;.
MutationTaster
Benign
D;D;D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
N;N;N;N;N;D;.
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;D;D;D;.
Sift4G
Uncertain
D;D;D;D;D;D;D
Polyphen
D;D;D;D;D;D;.
Vest4
MutPred
Loss of methylation at K303 (P = 0.018);Loss of methylation at K303 (P = 0.018);Loss of methylation at K303 (P = 0.018);.;Loss of methylation at K303 (P = 0.018);.;.;
MVP
MPC
2.5
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at